Negativibacillus massiliensis
DSM 103594
BACTERIA
How to read the following data (Example)
Name:
"Negativibacillus massiliensis" Ricaboni et al. 2017
DSM No.:
103594, Type strain
Strain designation:
Marseille-P3213
Other collection no.
or WDCM no.:
CSUR P3213
Isolated from:
Left colon sample from patient
Country:
France
Marseille
Date of sampling:
14-4-2016
Nagoya Protocol Restrictions:
France requires a benefit-sharing declaration for French genetic resources at the time of utilization, i.e., conducting research. France considers access to genetic resources when utilization begins and not when the initial collection of the material took place and applies to material both in-situ and ex-situ and users within and outside of France.
To comply with French law, you, the user need to make a Declaration regarding access to genetic resources and benefit-sharing arising from your non-commercial utilisation of genetic resources. The steps are the following:
1. File a declaration via the CERFA form n. 15786 (https://www.formulaires.service-public.fr/gf/getAnnexe.do?cerfaAnnexe=1&cerfaFormulaire=15786*02) or by electronic procedure (https://www.demarches-simplifiees.fr/commencer/apa-declaration-pmorale)
2. Await approval by the Ministry for the Ecological Transition, the competent national authority
3. Respond to any requests for more information from the competent national authority
4. Receive an acknowledgment of receipt by the competent national authority certifying the prior informed consent (PIC) and establishment of mutually agreed terms (MAT) regarding benefit-sharing. This procedure shall not exceed 2 months.
For more information about this topic please see the Access and Benefit-Sharing Clearing House: https://absch.cbd.int/en/countries/FR
For more information about the commercial use of this genetic resources please contact: justiziariat@dsmz.de
History:
<- F. Cadoret, CHU Hopital de la Timone, Marseille Cedex 05, France; Marseille-P3213
Genbank accession numbers:
16S rRNA gene: NR_147378
whole genome shotgun sequence: FTRU00000000
Cultivation conditions:
Medium 104 , anaerobic, 37°C
Please follow special instructions: 'Cultivation of Anaerobes'
Complete DSMZ Media List
Summary and
additional information:
<- F. Cadoret, CHU Hopital de la Timone, Marseille Cedex 05, France; Marseille-P3213. Left colon sample from patient. France, Marseille. Type strain.. Taxonomy/description (40174). Sequence accession no. 16S rRNA gene: NR_147378, whole genome shotgun sequence: FTRU00000000. (Medium 104, 37°C, anaerobic)
Literature:
40174
Risk group:
1 (provisional classification by DSMZ)
Supplied as:
Delivery form Prices
DSM103594
DSM 103594
BACTERIA
How to read the following data (Example)
Name:
"Negativibacillus massiliensis" Ricaboni et al. 2017
DSM No.:
103594, Type strain
Strain designation:
Marseille-P3213
Other collection no.
or WDCM no.:
CSUR P3213
Isolated from:
Left colon sample from patient
Country:
France
Marseille
Date of sampling:
14-4-2016
Nagoya Protocol Restrictions:
France requires a benefit-sharing declaration for French genetic resources at the time of utilization, i.e., conducting research. France considers access to genetic resources when utilization begins and not when the initial collection of the material took place and applies to material both in-situ and ex-situ and users within and outside of France.
To comply with French law, you, the user need to make a Declaration regarding access to genetic resources and benefit-sharing arising from your non-commercial utilisation of genetic resources. The steps are the following:
1. File a declaration via the CERFA form n. 15786 (https://www.formulaires.service-public.fr/gf/getAnnexe.do?cerfaAnnexe=1&cerfaFormulaire=15786*02) or by electronic procedure (https://www.demarches-simplifiees.fr/commencer/apa-declaration-pmorale)
2. Await approval by the Ministry for the Ecological Transition, the competent national authority
3. Respond to any requests for more information from the competent national authority
4. Receive an acknowledgment of receipt by the competent national authority certifying the prior informed consent (PIC) and establishment of mutually agreed terms (MAT) regarding benefit-sharing. This procedure shall not exceed 2 months.
For more information about this topic please see the Access and Benefit-Sharing Clearing House: https://absch.cbd.int/en/countries/FR
For more information about the commercial use of this genetic resources please contact: justiziariat@dsmz.de
History:
<- F. Cadoret, CHU Hopital de la Timone, Marseille Cedex 05, France; Marseille-P3213
Genbank accession numbers:
16S rRNA gene: NR_147378
whole genome shotgun sequence: FTRU00000000
Cultivation conditions:
Medium 104 , anaerobic, 37°C
Please follow special instructions: 'Cultivation of Anaerobes'
Complete DSMZ Media List
Summary and
additional information:
<- F. Cadoret, CHU Hopital de la Timone, Marseille Cedex 05, France; Marseille-P3213. Left colon sample from patient. France, Marseille. Type strain.. Taxonomy/description (40174). Sequence accession no. 16S rRNA gene: NR_147378, whole genome shotgun sequence: FTRU00000000. (Medium 104, 37°C, anaerobic)
Literature:
40174
Risk group:
1 (provisional classification by DSMZ)
Supplied as:
Delivery form Prices
DSM103594
